The renin–angiotensin–aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19

16Citations
Citations of this article
111Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 novel coronavirus, has spread worldwide causing high fatality rates. Neither a vaccine nor specific therapeutic approaches are available, hindering the fight against this disease and making better understanding of its pathogenesis essential. Despite similarities between SARS-CoV-2 and SARS-CoV, the former has unique characteristics which represent a great challenge to physicians. The mechanism of COVID-19 infection and pathogenesis is still poorly understood. In the present review, we highlight possible pathways involved in the pathogenesis of COVID-19 and potential therapeutic targets, focusing on the role of the renin–angiotensin–aldosterone system.

Cite

CITATION STYLE

APA

Braga, C. L., Silva-Aguiar, R. P., Battaglini, D., Peruchetti, D. B., Robba, C., Pelosi, P., … Silva, P. L. (2020, August 1). The renin–angiotensin–aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19. Pharmacology Research and Perspectives. Blackwell Publishing Ltd. https://doi.org/10.1002/prp2.623

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free